Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.019,90
-0,31%
NASDAQ Composite
15.614,07
-0,28%
Bitcoin
56.958,41
-6,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbSci Corporation (ABSI) AbSci Corporation (ABSI) Notizie

AbSci Corporation

ABSI
4,91
0,17 (3,59%)
Ultimo aggiornamento: 18:28:02
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202414:00GLOBEAbsci to Report Business Updates and First Quarter 2024..
28/3/202421:05GLOBEAbsci to Participate in the 23rd Annual Needham Virtual..
21/3/202412:30GLOBEAbsci Reports Business Updates and Fourth Quarter and Full..
01/3/202422:01GLOBEAbsci Announces Closing of Public Offering of Common Stock..
28/2/202422:06EDGAR2Form 8-K - Current report
28/2/202414:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202404:20GLOBEAbsci Announces Pricing of Public Offering of Common Stock
27/2/202422:45EDGAR2Form 8-K - Current report
27/2/202422:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202422:01GLOBEAbsci Announces Proposed Public Offering of Common Stock
21/2/202413:30GLOBEAbsci Initiates IND-Enabling Studies for ABS-101, a..
20/2/202414:00GLOBEAbsci to Participate in Upcoming Investor Conferences
14/2/202400:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202413:30GLOBEAbsci Appoints Professor Sir Mene Pangalos to its Board of..
08/1/202413:08EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEAbsci to Present Preclinical Data for ABS-101, A Potential..
04/1/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202414:00GLOBEAbsci to Participate in the 26th Annual Needham Growth..
28/12/202314:00GLOBEAbsci to Participate in the 42nd Annual J.P. Morgan..
20/12/202314:30EDGAR2Form 8-K - Current report
20/12/202313:30GLOBEAbsci and PrecisionLife Announce Strategic R&D Partnership..
07/12/202314:30EDGAR2Form 8-K - Current report
04/12/202316:41DJNAbsci Shares Rise 27% After Announcing Collaboration With..
04/12/202313:31EDGAR2Form 8-K - Current report
04/12/202313:30GLOBEAbsci Announces Collaboration with AstraZeneca to Advance..
15/11/202314:00GLOBEAbsci to Participate in the Piper Sandler 35th Annual..
14/11/202322:40EDGAR2Form 8-K - Current report
14/11/202322:05GLOBEAbsci Reports Business Updates and Third Quarter 2023..
14/11/202308:16BWAlmirall and Absci announce AI drug discovery partnership to..
14/11/202308:05GLOBEAlmirall and Absci announce AI drug discovery partnership to..
26/10/202314:00GLOBEAbsci to Participate in Upcoming Investor Conferences
17/10/202300:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202300:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202300:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202314:00GLOBEAbsci Announces Speaker Lineup for Inaugural R&D Day,..
06/9/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202314:00GLOBEAbsci to Host R&D Day on October 4, 2023
05/9/202314:15EDGAR2Form 8-K - Current report
28/8/202322:05GLOBEAbsci to Participate in Upcoming Investor Conferences
17/8/202323:02EDGAR2Form 8-K - Current report
14/8/202314:13EDGAR2Form 8-K - Current report
14/8/202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:02GLOBEAbsci Reports Business Updates and Second Quarter 2023..
14/8/202314:00GLOBEAbsci Appoints Zach Jonasson, Ph.D., as Chief Financial..
Apertura: 4,86 Min: 4,805 Max: 5,09
Chiusura: 4,74

La tua Cronologia

NASDAQ
ABSI
AbSci
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network